Yan Peng

2.3k total citations
60 papers, 1.9k citations indexed

About

Yan Peng is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Yan Peng has authored 60 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 27 papers in Oncology and 11 papers in Organic Chemistry. Recurrent topics in Yan Peng's work include Metal complexes synthesis and properties (17 papers), Cancer-related Molecular Pathways (7 papers) and Bioactive Compounds and Antitumor Agents (5 papers). Yan Peng is often cited by papers focused on Metal complexes synthesis and properties (17 papers), Cancer-related Molecular Pathways (7 papers) and Bioactive Compounds and Antitumor Agents (5 papers). Yan Peng collaborates with scholars based in China, United States and Canada. Yan Peng's co-authors include Yan‐Cheng Liu, Zhen‐Feng Chen, Hong Liang, Hong Liang, Shulin Zhao, Xiaoyan Song, Xiao‐Yong Zhang, Qing Huang, Wenxin Li and Ying Zhu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Yan Peng

56 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Peng China 24 848 674 520 355 301 60 1.9k
Julie A. Woods United Kingdom 29 1.1k 1.3× 1.2k 1.7× 945 1.8× 618 1.7× 168 0.6× 59 3.1k
Lanmei Chen China 27 1.6k 1.9× 1.1k 1.7× 1.0k 1.9× 439 1.2× 417 1.4× 78 3.2k
Jinxu Qi China 23 598 0.7× 627 0.9× 437 0.8× 328 0.9× 96 0.3× 45 1.4k
Ute Jungwirth Austria 20 633 0.7× 1.1k 1.6× 665 1.3× 163 0.5× 134 0.4× 30 1.9k
Shaohua Gou China 31 663 0.8× 1.2k 1.8× 1.2k 2.2× 430 1.2× 104 0.3× 115 2.3k
Wenjie Mei China 27 924 1.1× 909 1.3× 865 1.7× 304 0.9× 101 0.3× 116 2.0k
Pranav Gupta United States 29 1.8k 2.1× 2.1k 3.2× 702 1.4× 337 0.9× 369 1.2× 77 3.9k
Qiong Wu China 25 991 1.2× 844 1.3× 642 1.2× 437 1.2× 69 0.2× 95 2.1k
Maurizio Viale Italy 25 607 0.7× 634 0.9× 693 1.3× 116 0.3× 99 0.3× 116 2.1k
Ferda Arı Türkiye 25 570 0.7× 661 1.0× 597 1.1× 162 0.5× 144 0.5× 88 1.6k

Countries citing papers authored by Yan Peng

Since Specialization
Citations

This map shows the geographic impact of Yan Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Peng more than expected).

Fields of papers citing papers by Yan Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Peng. The network helps show where Yan Peng may publish in the future.

Co-authorship network of co-authors of Yan Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Peng. A scholar is included among the top collaborators of Yan Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Peng. Yan Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lei, Kai, et al.. (2025). Cracking the code of cancer immunotherapy resistance: emerging roles of pyroptosis and necroptosis. Journal of Experimental & Clinical Cancer Research. 44(1). 308–308.
3.
Wang, Yong, Lei Bao, Gonçalo Vale, et al.. (2025). ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27. Nature Communications. 16(1). 3908–3908. 3 indexed citations
4.
Li, Xinrui, Daniel Y. Song, Mingfeng Li, et al.. (2025). An initial exploration of core collection construction and DNA fingerprinting in Elymus sibiricus L. using SNP markers. Frontiers in Plant Science. 16. 1534085–1534085.
5.
Jin, Minghui, Hua Xiao, Yan Peng, et al.. (2025). Genomic predictions of invasiveness and adaptability of the cotton bollworm in response to climate change. Journal of genetics and genomics. 52(9). 1109–1120.
6.
Li, Yongkun, Xuesong Ma, Pingping Li, et al.. (2024). Pomalidomide sensitizes lung cancer cells to TRAIL/CDDP-induced apoptosis via directly targeting electron transfer flavoprotein alpha subunit. Bioorganic Chemistry. 153. 107815–107815. 1 indexed citations
7.
Li, Pingping, Yongkun Li, Liangping Li, et al.. (2024). Identification of naphthalimide-derivatives as novel PBD-targeted polo-like kinase 1 inhibitors with efficacy in drug-resistant lung cancer cells. European Journal of Medicinal Chemistry. 271. 116416–116416. 1 indexed citations
8.
Bao, Lei, Ashwani Kumar, Yan Peng, et al.. (2023). SAP30 promotes breast tumor progression by bridging the transcriptional corepressor SIN3 complex and MLL1. Journal of Clinical Investigation. 133(17). 4 indexed citations
9.
Li, Shijie, Yangyang Wang, Xiong Zhang, et al.. (2023). Mitochondrial damage-induced abnormal glucose metabolism with ageing in the hippocampus of APP/PS1 mice. Metabolomics. 19(6). 56–56. 10 indexed citations
10.
Feng, Xiaomeng, Jing Huang, Yan Peng, & Yuan Xu. (2021). Association between decreased thyroid stimulating hormone and hyperuricemia in type 2 diabetic patients with early-stage diabetic kidney disease. BMC Endocrine Disorders. 21(1). 1–1. 19 indexed citations
11.
Tao, Xi, et al.. (2019). Ozone alleviates ischemia/reperfusion injury by inhibiting mitochondrion‐mediated apoptosis pathway in SH‐SY5Y cells. Cell Biology International. 44(4). 975–984. 24 indexed citations
13.
Peng, Yan, Fenfang Zhou, Chi Zhang, et al.. (2017). Inhibition of adhesion and metastasis of HepG2 hepatocellular carcinoma cells in vitro by DNA aptamer against sialyl Lewis X. Journal of Huazhong University of Science and Technology [Medical Sciences]. 37(3). 343–347. 6 indexed citations
14.
Liu, Minjie, Yan Peng, Huayi Li, et al.. (2016). TaSYP71, a Qc-SNARE, Contributes to Wheat Resistance against Puccinia striiformis f. sp. tritici. Frontiers in Plant Science. 7. 544–544. 15 indexed citations
15.
Wang, Yan, et al.. (2014). The Clinical Value of LRRC3B Gene Expression and Promoter Hypermethylation in Breast Carcinomas. Cell Biochemistry and Biophysics. 70(2). 1035–1041. 5 indexed citations
16.
Chen, Zhen‐Feng, Yun‐Qiong Gu, Xiaoyan Song, et al.. (2012). Synthesis, crystal structure, cytotoxicity and DNA interaction of 5,7-dichloro-8-quinolinolato-lanthanides. European Journal of Medicinal Chemistry. 59. 194–202. 71 indexed citations
17.
Tian, Jianniao, et al.. (2012). Multiplexed detection of tumor markers with multicolor quantum dots based on fluorescence polarization immunoassay. Talanta. 92. 72–77. 98 indexed citations
18.
Chen, Zhen‐Feng, Yan‐Cheng Liu, Yan Peng, et al.. (2011). Synthesis, characterization, and in vitro antitumor properties of gold(III) compounds with the traditional Chinese medicine (TCM) active ingredient liriodenine. JBIC Journal of Biological Inorganic Chemistry. 17(2). 247–261. 29 indexed citations
19.
Tian, Jianniao, et al.. (2010). Synthesis of CdTe/CdS/ZnS quantum dots and their application in imaging of hepatocellular carcinoma cells and immunoassay for alpha fetoprotein. Nanotechnology. 21(30). 305101–305101. 36 indexed citations
20.
Chen, Zhen‐Feng, Li Mao, Yuandong Niu, et al.. (2010). Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) matrine with Ga(III), Au(III), Sn(IV) ions, and DNA binding studies. Journal of Inorganic Biochemistry. 105(2). 171–180. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026